Efforts are underway to bring to market a vaccine for a fungal infection that occurs in the deserts of the Southwest. With recent studies showing promise, there is a renewed push. Dr. John Galgiani, director of the University of Arizona's Valley Fever Center for Excellence, is heading up vaccine research there and believes the vaccine shown to prevent valley fever in mice should be available for dogs, which also get infected in large numbers, as soon as next year.

Steele Children’s Research Center director will be the initial holder of an endowed directorship in his name.

Funda Bachini, MD, answers back-to-school questions about children’s mental health.

For Eddie Case, his battle with COVID-19 didn't end when he went home from the hospital. In March, his symptoms were so severe he had to spend 20 days in a medically-induced coma. Six months later, he said his life isn't the same. "People have fatigue and confusion, difficulty focusing and concentrating," said Dr. Shad Marvasti, director of public health for the University of Arizona College of Medicine – Phoenix.

The antibody test determines who has been exposed to and developed an immune response against COVID-19.

University of Arizona students get tested for COVID-19 as part of the Test, Trace, Treat approach to preventing the pandemic’s spread.

Dr. Ole Thienhaus, chair of the Department of Psychiatry at the University of Arizona College of Medicine – Tucson, discusses the combined impact of long-term extreme heat and a pandemic on mental health.

In honor of Dr. Fayez K. Ghishan’s 25th anniversary as director of the Steele Children’s Research Center at the University of Arizona, members of the Phoenix Women’s Board of the Steele Children's Research Center have contributed $5 million to establish an endowment in his name. The endowment celebrates and honors Ghishan for his life’s work to improve treatment and seek cures for childhood diseases.

Efforts are underway to bring to market a vaccine for a fungal infection that occurs in the deserts of the Southwest. With recent studies showing promise, there is a renewed push. Dr. John Galgiani, director of the University of Arizona's Valley Fever Center for Excellence, is heading up vaccine research there and believes the vaccine shown to prevent valley fever in mice should be available for dogs, which also get infected in large numbers, as soon as next year. A veterinary vaccine company, Anivive, is developing it. "It's very promising," said Galgiani.